Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...

Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

These areas include cardiovascular, infectious diseases, and oncology, with notable brands like Comirnaty, Paxlovid, and Eliquis ... Consumer Banking & Lending, Commercial Banking, Corporate ...

Four top stocks have at least a 4% dividend and make sense for investors who may be worried about increased volatility in the stock market.

Realty Income is a net lease real estate investment trust (REIT) that has been increasing its portfolio of commercial real ... an upcoming patent cliff for Eliquis, a blood thinner Pfizer markets ...

It operates across multiple industry segments, including consumer and commercial banking ... including the anticoagulant Eliquis, which saw an 11% year-over-year sales increase, reaching $3 ...

SOTIC2’s commercial performance was lower than expected ... that we think has the potential to offer efficacy on a par with Eliquis, but with an improved bleeding profile. And we’re looking ...

She also served in assistant general counsel roles in oncology and commercial legal and compliance ... blockbuster drugs include blood thinner Eliquis and cancer drug Opdivo announced Leung's ...